News: Press Releases

During the medical device development process, the stakes rise with every stage, transitioning from concept discovery, to design iteration, preclinical testing, clinical testing, and finally, market launch. These stages often cross and blend together, but there is no denying that a major nail-biting moment is moving into initial clinical evaluation.

Let’s start with a hypothetical. A company spends three years building a team, iterating designs, screening materials, constructing a supply chain, conducting preliminary preclinical and functional evaluations, and building the bones of a design history file for an improved version of an existing medical device.

Cardiovascular medical devices are invented and used for a myriad of reasons. They maintain blood vessel flow lumens, exclude aneurysms and dissections, close orifices and communications, and even completely replace the function of valves, vessels, and membranes. However, with focused attention on the implant's primary functions, it is easy forget that an implant also has secondary objectives – to do no harm and stay intact. While loss of device integrity may not lead to immediate clinical sequelae, the potential risk for such events may increase over the lifetime of the device.

GST’s CEO and President Chieh-san Cheng recently announced a contract with the Air Force Research Laboratory (AFRL) to develop Weather Satellite (WeatherSat) sensor data processing algorithms, perform calibration/validation of the sensor data, and provide image processing in support of the AFRL small satellite weather mission.

Dr. Alejandro Egido will be honored at the next gathering of the Robert Goddard Memorial Dinner at the Robert Goddard Memorial Dinner for his novel analytic technique which improves along-track resolution of high-rate satellite radar altimeters.